A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is a 52 week double-blind placebo controlled study of omega-3 polyunsaturated fatty acids (PUFAs) in bipolar disorder (who have a history of 3 or more episodes) to ascertain if omega-3 PUFAs reduce the risk of further relapse for both / either depressive or (hypo)manic episodes. This is a single-centre, 52 week, double-blind, randomised comparison of omega-3 PUFA (1g EPA and 1g DHA) versus placebo as adjunctive treatment in individuals with bipolar disorder
Epistemonikos ID: 3f67e08340e48769b915cc49d0bfaaab05dac975
First added on: May 06, 2024